195 related articles for article (PubMed ID: 22948128)
1. Expression of corticotropin releasing factor receptor type 1 (CRF1) in the human gastrointestinal tract and upregulation in the colonic mucosa in patients with ulcerative colitis.
Yuan PQ; Wu SV; Elliott J; Anton PA; Chatzaki E; Million M; Taché Y
Peptides; 2012 Nov; 38(1):62-9. PubMed ID: 22948128
[TBL] [Abstract][Full Text] [Related]
2. Corticotropin-releasing factor receptor subtype 2 in human colonic mucosa: down-regulation in ulcerative colitis.
Chatzaki E; Anton PA; Million M; Lambropoulou M; Constantinidis T; Kolios G; Taché Y; Grigoriadis DE
World J Gastroenterol; 2013 Mar; 19(9):1416-23. PubMed ID: 23539366
[TBL] [Abstract][Full Text] [Related]
3. Urocortin and corticotropin-releasing factor receptor expression in the human colonic mucosa.
Muramatsu Y; Fukushima K; Iino K; Totsune K; Takahashi K; Suzuki T; Hirasawa G; Takeyama J; Ito M; Nose M; Tashiro A; Hongo M; Oki Y; Nagura H; Sasano H
Peptides; 2000 Dec; 21(12):1799-809. PubMed ID: 11150640
[TBL] [Abstract][Full Text] [Related]
4. Lesional accumulation of CD163-expressing cells in the gut of patients with inflammatory bowel disease.
Franzè E; Caruso R; Stolfi C; Sarra M; Cupi ML; Caprioli F; Monteleone I; Zorzi F; De Nitto D; Colantoni A; Biancone L; Pallone F; Monteleone G
PLoS One; 2013; 8(7):e69839. PubMed ID: 23922818
[TBL] [Abstract][Full Text] [Related]
5. Corticotropin releasing factor in the rat colon: expression, localization and upregulation by endotoxin.
Yuan PQ; Wu SV; Wang L; Taché Y
Peptides; 2010 Feb; 31(2):322-31. PubMed ID: 19944726
[TBL] [Abstract][Full Text] [Related]
6. VIP is involved in peripheral CRF-induced stimulation of propulsive colonic motor function and diarrhea in male rats.
Yakabi S; Wang L; Karasawa H; Yuan PQ; Koike K; Yakabi K; Taché Y
Am J Physiol Gastrointest Liver Physiol; 2018 May; 314(5):G610-G622. PubMed ID: 29420068
[TBL] [Abstract][Full Text] [Related]
7. Urocortin 2 expression in the rat gastrointestinal tract under basal conditions and in chemical colitis.
Chang J; Hoy JJ; Idumalla PS; Clifton MS; Pecoraro NC; Bhargava A
Peptides; 2007 Jul; 28(7):1453-60. PubMed ID: 17586086
[TBL] [Abstract][Full Text] [Related]
8. Expression of type 1 corticotropin-releasing factor receptor in the guinea pig enteric nervous system.
Liu S; Gao X; Gao N; Wang X; Fang X; Hu HZ; Wang GD; Xia Y; Wood JD
J Comp Neurol; 2005 Jan; 481(3):284-98. PubMed ID: 15593376
[TBL] [Abstract][Full Text] [Related]
9. Corticotropin releasing hormone in colonic mucosa in patients with ulcerative colitis.
Kawahito Y; Sano H; Mukai S; Asai K; Kimura S; Yamamura Y; Kato H; Chrousos GP; Wilder RL; Kondo M
Gut; 1995 Oct; 37(4):544-51. PubMed ID: 7489943
[TBL] [Abstract][Full Text] [Related]
10. Prediction of steroid demand in the treatment of patients with ulcerative colitis by immunohistochemical analysis of the mucosal microenvironment and immune checkpoint: role of macrophages and regulatory markers in disease severity.
Tsuda S; Carreras J; Kikuti YY; Nakae H; Dekiden-Monma M; Imai J; Tsuruya K; Nakamura J; Tsukune Y; Uchida T; Matsushima M; Roncador G; Suzuki T; Nakamura N; Mine T
Pathol Int; 2019 May; 69(5):260-271. PubMed ID: 30990953
[TBL] [Abstract][Full Text] [Related]
11. Peripheral corticotropin releasing factor (CRF) and a novel CRF1 receptor agonist, stressin1-A activate CRF1 receptor expressing cholinergic and nitrergic myenteric neurons selectively in the colon of conscious rats.
Yuan PQ; Million M; Wu SV; Rivier J; Taché Y
Neurogastroenterol Motil; 2007 Nov; 19(11):923-36. PubMed ID: 17973638
[TBL] [Abstract][Full Text] [Related]
12. Increased Th17-inducing activity of CD14+ CD163 low myeloid cells in intestinal lamina propria of patients with Crohn's disease.
Ogino T; Nishimura J; Barman S; Kayama H; Uematsu S; Okuzaki D; Osawa H; Haraguchi N; Uemura M; Hata T; Takemasa I; Mizushima T; Yamamoto H; Takeda K; Doki Y; Mori M
Gastroenterology; 2013 Dec; 145(6):1380-91.e1. PubMed ID: 23993972
[TBL] [Abstract][Full Text] [Related]
13. Reduction of CD68+ macrophages and decreased IL-17 expression in intestinal mucosa of patients with inflammatory bowel disease strongly correlate with endoscopic response and mucosal healing following infliximab therapy.
Caprioli F; Bosè F; Rossi RL; Petti L; Viganò C; Ciafardini C; Raeli L; Basilisco G; Ferrero S; Pagani M; Conte D; Altomare G; Monteleone G; Abrignani S; Reali E
Inflamm Bowel Dis; 2013; 19(4):729-39. PubMed ID: 23448791
[TBL] [Abstract][Full Text] [Related]
14. Potential Regulatory Effects of Corticotropin-Releasing Factor on Tight Junction-Related Intestinal Epithelial Permeability are Partially Mediated by CK8 Upregulation.
Yue H; Bin L; Chaoying C; Meng Z; Meng L; Xi W
Cell Physiol Biochem; 2017; 44(3):1161-1173. PubMed ID: 29179184
[TBL] [Abstract][Full Text] [Related]
15. Increased production of soluble TLR2 by lamina propria mononuclear cells from ulcerative colitis patients.
Candia E; Díaz-Jiménez D; Langjahr P; Núñez LE; de la Fuente M; Farfán N; López-Kostner F; Abedrapo M; Alvarez-Lobos M; Pinedo G; Beltrán CJ; González C; González MJ; Quera R; Hermoso MA
Immunobiology; 2012 Jun; 217(6):634-42. PubMed ID: 22101184
[TBL] [Abstract][Full Text] [Related]
16. Colon mucosa of patients both with spondyloarthritis and Crohn's disease is enriched with macrophages expressing the scavenger receptor CD163.
Demetter P; De Vos M; Van Huysse JA; Baeten D; Ferdinande L; Peeters H; Mielants H; Veys EM; De Keyser F; Cuvelier CA
Ann Rheum Dis; 2005 Feb; 64(2):321-4. PubMed ID: 15166002
[TBL] [Abstract][Full Text] [Related]
17. Mucosal synthesis and release of prostaglandin E2 from activated eosinophils and macrophages in ulcerative colitis.
Raab Y; Sundberg C; Hällgren R; Knutson L; Gerdin B
Am J Gastroenterol; 1995 Apr; 90(4):614-20. PubMed ID: 7717321
[TBL] [Abstract][Full Text] [Related]
18. Eosinophils express muscarinic receptors and corticotropin-releasing factor to disrupt the mucosal barrier in ulcerative colitis.
Wallon C; Persborn M; Jönsson M; Wang A; Phan V; Lampinen M; Vicario M; Santos J; Sherman PM; Carlson M; Ericson AC; McKay DM; Söderholm JD
Gastroenterology; 2011 May; 140(5):1597-607. PubMed ID: 21277851
[TBL] [Abstract][Full Text] [Related]
19. [Expression of co-stimulators in ulcerative colitis and its pathologic significance].
Li F; Chen AJ; Du J; Zhang Y; Gong EC; Shi XY
Zhonghua Bing Li Xue Za Zhi; 2010 Jan; 39(1):19-24. PubMed ID: 20388394
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis in the intestinal mucosa of patients with inflammatory bowel disease: evidence of altered expression of FasL and perforin cytotoxic pathways.
Souza HS; Tortori CJ; Castelo-Branco MT; Carvalho AT; Margallo VS; Delgado CF; Dines I; Elia CC
Int J Colorectal Dis; 2005 May; 20(3):277-86. PubMed ID: 15503066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
